Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more

Industry Leaders Discuss the Impact of FDA's Diversity Action Plan

Pamela Tenaerts, MD, MBA, chief scientific officer, Medable; Luke Gelinas, PhD, senior chair director, Advarra; and Pam Diamond, MD, chief medical officer & co-founder, Curavit highlight the potential impact FDA's Diversity Action Plan guidance will have on industry.

Early Vaccine Study Shows HIV Neutralizing Antibodies Appear Within Weeks

Elusive HIV antibodies were triggered within weeks during a small-scale HIV vaccine study done at the Duke Human Vaccine Institute, according to a press release posted last month. This finding is significant because it can take years for the body to establish these antibodies. The research was published mid-May in the journal Cell.

Apple Poised to Get OpenAI Board Observer Role as Part of AI Pact

Apple Inc. will get an observer role on OpenAI’s board as part of a landmark agreement announced last month, further tightening ties between the once-unlikely partners.

Annual Life Sciences GMP (Good Manufacturing Practices) Master Class 2024

The "Annual GMP Master Class 2024" training has been added to ResearchAndMarkets.com's offering.

cGMPs or Current Good Manufacturing Practices is a general encompassing term for the regulations that the control of all facets of life sciences manufacturing processes and facilities particularly pharmaceutical products.

Cencora on LinkedIn

How can distributors ensure urgent drug recalls are handled as efficiently as possible?

Our Medication Trays used with RFID technology solve data management issues in the drug recall process, which saves time and effort for hospital pharmacies. Read our VP of Product Management, Global Products & Solutions Beth Riggio’s interview about it in Pharmaceutical Executive: https://ow.ly/iFrv50SuzaA

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs